Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2022-11-29 00:00:00 ET · period of report 2022-11-25 · accession 0001367644-22-000148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-29 | 2022-11-25 | EBS | Richard Ronald | Dir | S - Sale | $11.94 | -1,912 | 19.8K | -9% | -$22.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-25 | S | D | 1,912 | $11.94 | 19,837 | D | — | — | (F1) Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. |